No results for ‘’
Trident Texofab Ltd
₹22.30
(3.34%)
Mon, 21 Sept 2026, 07:56 pm
Process Industries
Textiles
24.5KTrident Texofab Return on Equity (ROE) History
| Particulars | 2019 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Price to earnings ratio | 48.20 | 26.12 | 45.52 | 81.46 |
| Price to book ratio | 3.49 | 3.82 | 3.02 | 5.02 |
| Price to sales ratio | 0.46 | 0.60 | 0.49 | 1.68 |
| Price to cash flow ratio | 0 | 22.52 | 0 | 0 |
| Enterprise value | 64.25Cr | 95.65Cr | 89.12Cr | 231Cr |
| Enterprise value to EBITDA ratio | 14.06 | 15.16 | 14.51 | 42.20 |
| Debt to equity ratio | 1.93 | 2.49 | 2.47 | 0.63 |
| Return on equity % | 0 | 0 | 6.87 | 7.91 |
Trident Texofab Ltd Return on Equity
The Trident Texofab Ltd Return on Equity is a key financial metric used by investors to evaluate Trident Texofab Ltd's valuation, profitability, and overall financial performance. Tracking the Trident Texofab Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Trident Texofab Ltd (NSE: , BSE: 540726) is currently trading at ₹22.30, with a market capitalization of ₹33.32Cr. As a leading company in the Process industries sector and Textiles industry, monitoring the Trident Texofab Ltd Return on Equity is essential for fundamental analysis.
Trident Texofab Ltd Return on Equity Current Value
The current Trident Texofab Ltd Return on Equity stands at 7.91.
The latest Trident Texofab Ltd Return on Equity has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Trident Texofab Ltd Return on Equity Historical Trend
The Trident Texofab Ltd Return on Equity has shown the following historical trend:
- 2024: 7.91
- 2023: 6.87
- 2022: 0
- 2019: 0
The recent rise in Trident Texofab Ltd Return on Equity suggests strengthening valuation trends and improving market sentiment.
What Trident Texofab Ltd Return on Equity Indicates for Investors
The Trident Texofab Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.
ROE indicates how efficiently the company generates returns for shareholders.
Trident Texofab Ltd Return on Equity Analysis Summary
The Trident Texofab Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Trident Texofab Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Trident Texofab Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.